Park Dental Partners, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Park Dental Partners, Inc. (PARK) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$88.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- Park Dental Partners, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$1.03M.
- Park Dental Partners, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $942.00K, a 15.89% decline year-over-year.
- Park Dental Partners, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-06-30 was -$124.00K.
- Park Dental Partners, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-03-31 was $1.12M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month |
|---|---|---|
| 2026-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$88.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $942.00K 10-Q · filed 2026-05-14 | |
| 2025-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $996.00K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.12M 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |